Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

KIR3DL1/S1 Allotypes Contribute Differentially to the Development of Behçet Disease.

Petrushkin H, Norman PJ, Lougee E, Parham P, Wallace GR, Stanford MR, Fortune F.

J Immunol. 2019 Aug 12. pii: ji1801178. doi: 10.4049/jimmunol.1801178. [Epub ahead of print]

PMID:
31405953
2.

Isolated endogenous Fusarium endophthalmitis in an immunocompetent adult after a thorn prick to the hand.

Milligan AL, Gruener AM, Milligan ID, O'Hara GA, Stanford MR.

Am J Ophthalmol Case Rep. 2016 Dec 30;6:45-47. doi: 10.1016/j.ajoc.2016.12.017. eCollection 2017 Jun.

3.

A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet's Syndrome.

Khan E, Ambrose NL, Ahnström J, Kiprianos AP, Stanford MR, Eleftheriou D, Brogan PA, Mason JC, Johns M, Laffan MA, Haskard DO.

Sci Rep. 2016 Dec 7;6:38104. doi: 10.1038/srep38104.

4.

Aspergillus fumigatus Endophthalmitis with Necrotizing Scleritis following Pars Plana Vitrectomy.

Gruener AM, Allen F, Stanford MR, Graham EM.

Case Rep Ophthalmol Med. 2016;2016:9289532. doi: 10.1155/2016/9289532. Epub 2016 Jun 9.

5.

Behçet's Disease: Do Natural Killer Cells Play a Significant Role?

Petrushkin H, Hasan MS, Stanford MR, Fortune F, Wallace GR.

Front Immunol. 2015 Mar 24;6:134. doi: 10.3389/fimmu.2015.00134. eCollection 2015. Review.

6.

Genome-wide association study in an admixed case series reveals IL12A as a new candidate in Behçet disease.

Kappen JH, Medina-Gomez C, van Hagen PM, Stolk L, Estrada K, Rivadeneira F, Uitterlinden AG, Stanford MR, Ben-Chetrit E, Wallace GR, Soylu M, van Laar JA.

PLoS One. 2015 Mar 23;10(3):e0119085. doi: 10.1371/journal.pone.0119085. eCollection 2015.

7.

Possession of the HLA-DRB1*1501 allele and visual outcome in idiopathic intermediate uveitis.

Petrushkin H, Thomas D, Vaughan R, Kondeatis E, Stanford MR, Edelsten C, Wallace GR.

JAMA Ophthalmol. 2015 Apr;133(4):482-3. doi: 10.1001/jamaophthalmol.2014.5868. No abstract available.

PMID:
25634309
8.

Therapy for ocular toxoplasmosis--the future.

Garweg JG, Stanford MR.

Ocul Immunol Inflamm. 2013 Aug;21(4):300-5. doi: 10.3109/09273948.2013.779724. Epub 2013 Apr 25. Review.

PMID:
23617277
9.

Author response: predictors of visual acuity in macular edema.

Pelosini L, Hull CC, Boyce JF, McHugh D, Stanford MR, Marshall J.

Invest Ophthalmol Vis Sci. 2012 Feb 21;53(2):924. doi: 10.1167/iovs.11-9278. No abstract available.

PMID:
22354951
10.

Cutaneous γδ T-cell lymphoma with bilateral ocular and adnexal involvement.

Shunmugam M, Chan E, O'Brart D, Moonim MT, Stanford MR, Morley AM.

Arch Ophthalmol. 2011 Oct;129(10):1379-81. doi: 10.1001/archophthalmol.2011.317. No abstract available.

PMID:
21987688
11.

Case report: ampiginous chorioretinopathy associated with eales disease in a patient with presumed tuberculosis.

Wong R, Graham EM, Scoppettuolo E, Mohamed M, Stanford MR.

Retin Cases Brief Rep. 2011 Summer;5(3):249-50. doi: 10.1097/ICB.0b013e3181ef4490.

PMID:
25390176
12.

TIRAP Ser180Leu polymorphism is associated with Behcet's disease.

Durrani O, Banahan K, Sheedy FJ, McBride L, Ben-Chetrit E, Greiner K, Vaughan RW, Kondeatis E, Hamburger J, Fortune F, Stanford MR, Murray PI, O'Neill LA, Wallace GR.

Rheumatology (Oxford). 2011 Oct;50(10):1760-5. doi: 10.1093/rheumatology/ker200. Epub 2011 Jun 24.

PMID:
21705416
13.

Immune choroiditis following contralateral acute retinal necrosis.

Wong R, Graham EM, Mohamed M, Stanford MR.

Arch Ophthalmol. 2010 Oct;128(10):1364-6. doi: 10.1001/archophthalmol.2010.219. No abstract available.

PMID:
20938010
14.

Use of the double-pass technique to quantify ocular scatter in patients with uveitis: a pilot study.

Nanavaty MA, Stanford MR, Sharma R, Dhital A, Spalton DJ, Marshall J.

Ophthalmologica. 2011;225(1):61-6. doi: 10.1159/000316690. Epub 2010 Aug 14.

PMID:
20714184
15.

Optical coherence tomography may be used to predict visual acuity in patients with macular edema.

Pelosini L, Hull CC, Boyce JF, McHugh D, Stanford MR, Marshall J.

Invest Ophthalmol Vis Sci. 2011 Apr 25;52(5):2741-8. doi: 10.1167/iovs.09-4493.

PMID:
20538987
16.

Visual loss and falls: a review.

Dhital A, Pey T, Stanford MR.

Eye (Lond). 2010 Sep;24(9):1437-46. doi: 10.1038/eye.2010.60. Epub 2010 May 7. Review.

PMID:
20448666
17.

Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome.

Wong R, Pavesio CE, Laidlaw DA, Williamson TH, Graham EM, Stanford MR.

Ophthalmology. 2010 Mar;117(3):556-60. doi: 10.1016/j.ophtha.2009.08.003. Epub 2009 Dec 23.

PMID:
20031221
18.

Intravitreal bevacizumab to facilitate vitrectomy in idiopathic ischaemic retinal vasculitis.

Wong R, Gupta B, Stanford MR, Laidlaw DA.

Int Ophthalmol. 2010 Aug;30(4):415-9. doi: 10.1007/s10792-009-9329-4. Epub 2009 Dec 10.

PMID:
20012158
19.

Low prevalence of NOD2 SNPs in Behçet's disease suggests protective association in Caucasians.

Kappen JH, Wallace GR, Stolk L, Rivadeneira F, Uitterlinden AG, van Daele PL, Laman JD, Kuijpers RW, Baarsma GS, Stanford MR, Fortune F, Madanat W, van Hagen PM, van Laar JA.

Rheumatology (Oxford). 2009 Nov;48(11):1375-7. doi: 10.1093/rheumatology/kep292. Epub 2009 Sep 11.

PMID:
19748964
20.

Low prevalence of juvenile-onset Behcet's disease with uveitis in East/South Asian people.

Kitaichi N, Miyazaki A, Stanford MR, Iwata D, Chams H, Ohno S.

Br J Ophthalmol. 2009 Nov;93(11):1428-30. doi: 10.1136/bjo.2008.154476. Epub 2009 Aug 9.

21.

Treating ocular toxoplasmosis: current evidence.

Stanford MR, Gilbert RE.

Mem Inst Oswaldo Cruz. 2009 Mar;104(2):312-5. Review.

22.

Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohort.

Martin TM, Bye L, Modi N, Stanford MR, Vaughan R, Smith JR, Wade NK, Mackensen F, Suhler EB, Rosenbaum JT, Wallace GR.

Mol Vis. 2009;15:208-12. Epub 2009 Jan 26.

23.

Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination.

Dodds EM, Holland GN, Stanford MR, Yu F, Siu WO, Shah KH, Ten Dam-van Loon N, Muccioli C, Hovakimyan A, Barisani-Asenbauer T; International Ocular Toxoplasmosis Research Group.

Am J Ophthalmol. 2008 Dec;146(6):856-65.e2. doi: 10.1016/j.ajo.2008.09.006.

PMID:
19027421
24.

Serum cytokine profiles in Behçet's disease: is there a role for IL-15 in pathogenesis?

Curnow SJ, Pryce K, Modi N, Knight B, Graham EM, Stewart JE, Fortune F, Stanford MR, Murray PI, Wallace GR.

Immunol Lett. 2008 Nov 16;121(1):7-12. doi: 10.1016/j.imlet.2008.07.009. Epub 2008 Aug 13.

PMID:
18706446
25.

Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe.

Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LM, Tan HK, Wallon M, Buffolano W, Stanford MR, Petersen E; European Multicentre Study on Congenital Toxoplasmosis (EMSCOT).

PLoS Negl Trop Dis. 2008 Aug 13;2(8):e277. doi: 10.1371/journal.pntd.0000277.

26.

Tuberculous orbital apex syndromes.

Hughes EH, Petrushkin H, Sibtain NA, Stanford MR, Plant GT, Graham EM.

Br J Ophthalmol. 2008 Nov;92(11):1511-7. doi: 10.1136/bjo.2008.138974. Epub 2008 Jul 9.

PMID:
18614572
27.

Immunity and Toxoplasma retinochoroiditis.

Wallace GR, Stanford MR.

Clin Exp Immunol. 2008 Sep;153(3):309-15. doi: 10.1111/j.1365-2249.2008.03692.x. Epub 2008 Jun 28. Review.

28.

CTLA-4 polymorphisms are not associated with ocular inflammatory disease.

Bye L, Modi N, Stanford MR, Kondeatis E, Vaughan R, Fortune F, Kanawati C, Ben-Chetrit E, Ghabra M, Murray PI, Wallace GR.

Tissue Antigens. 2008 Jul;72(1):49-53. doi: 10.1111/j.1399-0039.2008.01062.x. Epub 2008 May 20.

PMID:
18498289
29.

Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease.

Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H.

Ann Rheum Dis. 2009 Oct;68(10):1528-34. doi: 10.1136/ard.2008.087957. Epub 2008 Apr 17. Review.

PMID:
18420940
30.

EULAR recommendations for the management of Behçet disease.

Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H; EULAR Expert Committee.

Ann Rheum Dis. 2008 Dec;67(12):1656-62. doi: 10.1136/ard.2007.080432. Epub 2008 Jan 31.

PMID:
18245110
31.

Ocular features of Behcet's disease: an international collaborative study.

Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H.

Br J Ophthalmol. 2007 Dec;91(12):1579-82.

32.

The association of the PTPN22 620W polymorphism with Behcet's disease.

Baranathan V, Stanford MR, Vaughan RW, Kondeatis E, Graham E, Fortune F, Madanat W, Kanawati C, Ghabra M, Murray PI, Wallace GR.

Ann Rheum Dis. 2007 Nov;66(11):1531-3. Epub 2007 Jul 27.

33.

Systematic review of ethnic variation in the phenotype of Behcet's disease.

Lewis KA, Graham EM, Stanford MR.

Scand J Rheumatol. 2007 Jan-Feb;36(1):1-6. Review.

PMID:
17454928
34.

IL-10 genotype analysis in patients with Behçet's disease.

Wallace GR, Kondeatis E, Vaughan RW, Verity DH, Chen Y, Fortune F, Madanat W, Kanawati CA, Graham EM, Stanford MR.

Hum Immunol. 2007 Feb;68(2):122-7. Epub 2006 Dec 27.

PMID:
17321902
35.

Low-dose intra-venous cyclophosphamide therapy in a patient with neurological complications of Behçet's disease.

Melillo N, Sangle S, Stanford MR, Andrews TC, D'Cruz DP.

Clin Rheumatol. 2007 Aug;26(8):1365-7. Epub 2006 Oct 25.

PMID:
17063282
36.

Sudden loss of vision caused by a vasculitic ophthalmic artery occlusion in a patient with ankylosing spondylitis and Crohn's disease.

Soomro H, Armstrong M, Graham EM, Stanford MR.

Br J Ophthalmol. 2006 Nov;90(11):1438. No abstract available.

37.

Expression analysis of immune response genes of Müller cells infected with Toxoplasma gondii.

Knight BC, Kissane S, Falciani F, Salmon M, Stanford MR, Wallace GR.

J Neuroimmunol. 2006 Oct;179(1-2):126-31. Epub 2006 Aug 24.

PMID:
16934877
38.

Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK survey.

Stanford MR, Tan HK, Gilbert RE.

Br J Ophthalmol. 2006 Dec;90(12):1464-7. Epub 2006 Aug 9.

39.

A CX3CR1 genotype associated with retinal vasculitis in patients in the United Kingdom.

Wallace GR, Vaughan RW, Kondeatis E, Mathew R, Chen Y, Graham EM, Stanford MR.

Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2966-70.

PMID:
16799040
40.

Diagnosis of Treponema pallidum in vitreous samples using real time polymerase chain reaction.

Rajan MS, Pantelidis P, Tong CY, French GL, Graham EM, Stanford MR.

Br J Ophthalmol. 2006 May;90(5):647-8. No abstract available.

41.

Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome.

Angunawela RI, Heatley CJ, Williamson TH, Spalton DJ, Graham EM, Antcliffe RJ, Stanford MR.

Acta Ophthalmol Scand. 2005 Oct;83(5):595-9.

42.

Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet's disease in Caucasian patients.

Hughes EH, Collins RW, Kondeatis E, Wallace GR, Graham EM, Vaughan RW, Stanford MR.

Tissue Antigens. 2005 Sep;66(3):195-9.

PMID:
16101830
43.

Streptococcus anginosus-associated endogenous endophthalmitis mimicking fungal endophthalmitis.

Hadid OH, Shah SP, Sherafat H, Graham EM, Stanford MR.

J Clin Microbiol. 2005 Aug;43(8):4275-6. No abstract available.

44.

Are cytokine gene polymorphisms associated with outcome in patients with idiopathic intermediate uveitis in the United Kingdom?

Stanford MR, Vaughan RW, Kondeatis E, Chen Y, Edelsten CE, Graham EM, Wallace GR.

Br J Ophthalmol. 2005 Aug;89(8):1013-6.

45.

The visual field in toxoplasmic retinochoroiditis.

Stanford MR, Tomlin EA, Comyn O, Holland K, Pavesio C.

Br J Ophthalmol. 2005 Jul;89(7):812-4.

46.

Acute retinal necrosis presenting as central retinal artery occlusion with cilioretinal sparing.

Shah SP, Hadid OH, Graham EM, Stanford MR.

Eur J Ophthalmol. 2005 Mar-Apr;15(2):287-8.

PMID:
15812776
47.

The effect of Toxoplasma gondii infection on expression of chemokines by rat retinal vascular endothelial cells.

Knight BC, Brunton CL, Modi NC, Wallace GR, Stanford MR.

J Neuroimmunol. 2005 Mar;160(1-2):41-7. Epub 2004 Dec 19.

PMID:
15710456
48.

HACEK endocarditis causing endogenous endophthalmitis and a metastatic abscess.

Moradi P, Roberton B, Osborne R, Muhtaseb M, Graham EM, Klein J, Stanford MR.

Eye (Lond). 2006 Feb;20(2):254-5. No abstract available.

PMID:
15688044
49.

Safety testing of infracyanine green using retinal pigment epithelium and glial cell cultures.

Jackson TL, Vote B, Knight BC, El-Amir A, Stanford MR, Marshall J.

Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3697-703.

PMID:
15452079
50.

Steroid prophylaxis in eyes with uveitis undergoing phacoemulsification.

Meacock WR, Spalton DJ, Bender L, Antcliff R, Heatley C, Stanford MR, Graham EM.

Br J Ophthalmol. 2004 Sep;88(9):1122-4.

Supplemental Content

Loading ...
Support Center